1996
DOI: 10.1016/s0901-5027(96)80009-9
|View full text |Cite
|
Sign up to set email alerts
|

Cancer of the nasal cavity and paranasal sinuses: A new staging system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2001
2001
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 12 publications
0
15
0
Order By: Relevance
“…However, there are only isolated case reports of CEPA in which the carcinoma is ACC [6,7,18,23]. Other carcinomas, such as mucoepidermoid carcinoma [18,24,25], squamous cell carcinoma [18] and adenocarcinoma, not otherwise specified (NOS), [6,23] are also recognized but are equally infrequent. Benign salivary gland neoplasms are less common than malignant tumors, and include pleomorphic adenoma, myoepithelioma, and oncocytoma.…”
Section: Discussionmentioning
confidence: 99%
“…However, there are only isolated case reports of CEPA in which the carcinoma is ACC [6,7,18,23]. Other carcinomas, such as mucoepidermoid carcinoma [18,24,25], squamous cell carcinoma [18] and adenocarcinoma, not otherwise specified (NOS), [6,23] are also recognized but are equally infrequent. Benign salivary gland neoplasms are less common than malignant tumors, and include pleomorphic adenoma, myoepithelioma, and oncocytoma.…”
Section: Discussionmentioning
confidence: 99%
“…The staging system takes into consideration the epicenter of the tumor in these sites and subsites at the time of diagnosis and places them in the context of extension into bone and neighboring sites and structures, including the oral cavity, soft tissues of the cheek and nose, pterygomaxillary fossa, orbit, pituitary, and skull base (including intracranial extension) (Fig. 1) [17,135]. These determinations were drawn from an analysis of the clinical, imaging and/or operative data.…”
Section: Methodsmentioning
confidence: 99%
“…Articles that employed a staging system for patients with nasal and ethmoid carcinoma were sparse, and the classification systems used varied 4,29,30,77,100,109,151,165,171,188,196,203 and sometimes were arbitrary 57,74,107,108,110,130,156,162,204 -206 Only one previous study used a similar classification system in 54 patients with nasal and paranasal carcinoma 183 It is difficult to compare our data in terms of disease stage for these locations until a universal staging system is adopted. For this study, we reluctantly abandoned the staging system that we proposed several years ago for patients with esthesioneuroblastoma 4,207 in favor of the UICC classification system in the search for such a consensus.…”
Section: T Classificationmentioning
confidence: 99%